Antibody-Drug Conjugates

Biopharmaceutical excipients are the inactive substances added to biologic drug products to protect large, structurally fragile biomolecules, such as monoclonal...

This year, the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology took place in Prague, Czech Republic. We show...

Abstract Formulation development of protein biopharmaceuticals has become increasingly challenging due to new modalities and higher target drug substance concentrations....

CPhI Frankfurt and AAPS PharmSci 360 Review Ashland showed multiple new and optimized pharmaceutical product offerings during CPHI Frankfurt and...

Abstract Peptide therapeutics are important in healthcare owing to their high target specificity, therapeutic efficacy, and relatively low side effect...

Moving Glycoscience Forward How does the Sucrose SG product’s manufacturing process fit into your company’s strong sustainability commitments? Our proprietary...

Abstract Nanomedicines are extensively explored for cancer therapy. By delivering drug molecules more efficiently to pathological sites and by attenuating...

A total of 378 novel drugs and 27 biosimilars approved by the U.S. Food and Drug Administration (FDA) between 2010...

By: Ben Nelson, PhD, and Chris Wilcox   Trehalose is a non-reducing disaccharide consisting of two glucose molecules linked by...